Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2011, Article ID 947246, 5 pages
http://dx.doi.org/10.4061/2011/947246
Review Article

Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners

1Department of Cardiology, Elena Venizelou Hospital, 2 Elena Venizelou Sqr., Athens 11521, Greece
2Department of Cardiology, Metaxa Cancer Hospital, 51 Mpotassi Str., Piraeus 18537, Greece
3First Cardiology Clinic, University of Athens, Hippokration Hospital, 114 Vas. Sofias Str., Athens 11527, Greece

Received 14 October 2010; Accepted 8 December 2010

Academic Editor: Vasilios Papademetriou

Copyright © 2011 Costas Thomopoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Lavie, P. Herer, and V. Hoffstein, “Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study,” British Medical Journal, vol. 320, no. 7233, pp. 479–482, 2000. View at Google Scholar · View at Scopus
  2. F. Javier Nieto, T. B. Young, and T. B. Young, “Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study,” Journal of the American Medical Association, vol. 283, no. 14, pp. 1829–1836, 2000. View at Google Scholar · View at Scopus
  3. O. Friedman and A. G. Logan, “The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects,” American Journal of Hypertension, vol. 22, no. 5, pp. 474–483, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. Tsioufis, A. Kasiakogias, C. Thomopoulos, A. Manolis, and C. Stefanadis, “Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy,” Journal of Hypertension, vol. 28, no. 5, pp. 875–882, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. Tsioufis, C. Thomopoulos, and C. Stefanadis, “Obstructive sleep apnoea and hypertension: a growing clinical challenge,” Hellenic Journal of Cardiology, vol. 49, no. 5, pp. 299–302, 2008. View at Google Scholar · View at Scopus
  6. T. L. Goodfriend, “Obesity, sleep apnea, aldosterone, and hypertension,” Current Hypertension Reports, vol. 10, no. 3, pp. 222–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Garrison, W. B. Kannel, J. Stokes, and W. P. Castelli, “Incidence and precursors of hypertension in young adults: the Framingham offspring study,” Preventive Medicine, vol. 16, no. 2, pp. 235–251, 1987. View at Google Scholar · View at Scopus
  8. A. V. Chobanian, G. L. Bakris, and G. L. Bakris, “The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. Mancia, G. De Backer, and G. De Backer, “2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension,” Journal of Hypertension, vol. 25, no. 9, pp. 1751–1762, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. O. Marrone, C. Lombardi, and G. Parati, “Effects of continuous positive airway pressure therapy on hypertension control in patients with sleep-related breathing disorders: available evidence and unresolved issues,” Journal of Hypertension, vol. 28, no. 10, pp. 2012–2015, 2010. View at Publisher · View at Google Scholar · View at PubMed
  11. K. M. Rexrode, J. E. Manson, and C. H. Hennekens, “Obesity and cardiovascular disease,” Current Opinion in Cardiology, vol. 11, no. 5, pp. 490–495, 1996. View at Google Scholar · View at Scopus
  12. P. Bramlage, D. Pittrow, and D. Pittrow, “Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled,” American Journal of Hypertension, vol. 17, no. 10, pp. 904–910, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. W. C. Cushman, C. E. Ford, and C. E. Ford, “Success and predictors of blood pressure control in diverse North American settings: te antihypertensive and lipid-lowering treatment to prevent heart attact trial (ALLHAT),” Journal of Clinical Hypertension, vol. 4, no. 6, pp. 393–404, 2002. View at Google Scholar
  14. W. G. Haynes, “Role of leptin in obesity-related hypertension,” Experimental Physiology, vol. 90, no. 5, pp. 683–688, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. N. Tümer, B. Erdös, M. Matheny, I. Cudykier, and P. J. Scarpace, “Leptin antagonist reverses hypertension caused by leptin overexpression, but fails to normalize obesity-related hypertension,” Journal of Hypertension, vol. 25, no. 12, pp. 2471–2478, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. C. Thomopoulos, D. P. Papadopoulos, and D. P. Papadopoulos, “Free leptin is associated with masked hypertension in nonobese subjects a cross-sectional study,” Hypertension, vol. 53, no. 6, pp. 965–972, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. Schäfer, D. Pauleit, T. Sudhop, I. Gouni-Berthold, S. Ewig, and H. K. Berthold, “Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea,” Chest, vol. 122, no. 3, pp. 829–839, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Hall, “The kidney, hypertension, and obesity,” Hypertension, vol. 41, no. 3, pp. 625–633, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. C. Tsioufis, C. Thomopoulos, and C. Thomopoulos, “Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study,” American Journal of Kidney Diseases, vol. 52, no. 2, pp. 285–293, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. Damman, V. M. van Deursen, G. Navis, A. A. Voors, D. J. van Veldhuisen, and H. L. Hillege, “Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease,” Journal of the American College of Cardiology, vol. 53, no. 7, pp. 582–588, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. T. L. Goodfriend and D. A. Calhoun, “Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy,” Hypertension, vol. 43, no. 3, pp. 518–524, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. D. A. Calhoun, M. K. Nishizaka, M. A. Zaman, and S. M. Harding, “Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea,” Chest, vol. 125, no. 1, pp. 112–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Tsioufis, K. Thomopoulos, and K. Thomopoulos, “The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects,” Journal of Hypertension, vol. 25, no. 1, pp. 141–146, 2007. View at Publisher · View at Google Scholar · View at PubMed
  24. J. E. Dimsdale, T. Coy, M. G. Ziegler, S. Ancoli-Israel, and J. Clausen, “The effect of sleep apnea on plasma and urinary catecholamines,” Sleep, vol. 18, no. 5, pp. 377–381, 1995. View at Google Scholar
  25. C. Thomopoulos, C. Tsioufis, and C. Tsioufis, “Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives,” Journal of Human Hypertension, vol. 23, no. 1, pp. 65–67, 2009. View at Publisher · View at Google Scholar · View at PubMed
  26. A. G. Logan, S. M. Perlikowski, and S. M. Perlikowski, “High prevalence of unrecognized sleep apnoea in drug-resistant hypertension,” Journal of Hypertension, vol. 19, no. 12, pp. 2271–2277, 2001. View at Publisher · View at Google Scholar
  27. P. Ruttanaumpawan, C. Nopmaneejumruslers, A. G. Logan, A. Lazarescu, I. Qian, and T. D. Bradley, “Association between refractory hypertension and obstructive sleep apnea,” Journal of Hypertension, vol. 27, no. 7, pp. 1439–1445, 2009. View at Publisher · View at Google Scholar · View at PubMed
  28. S. C. Gonçalves, D. Martinez, and D. Martinez, “Obstructive sleep apnea and resistant hypertension: a case-control study,” Chest, vol. 132, no. 6, pp. 1858–1862, 2007. View at Publisher · View at Google Scholar · View at PubMed
  29. M. A. Martínez-García, R. Gómez-Aldaraví, T. Gil-Martínez, J. J. Soler-Cataluña, B. Bernácer-Alpera, and P. Román-Sánchez, “Sleep-disordered breathing in patients with difficult-to-control hypertension,” Archivos de Bronconeumologia, vol. 42, no. 1, pp. 14–20, 2006. View at Publisher · View at Google Scholar
  30. M. N. Pratt-Ubunama, M. K. Nishizaka, R. L. Boedefeld, S. S. Cofield, S. M. Harding, and D. A. Calhoun, “Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension,” Chest, vol. 131, no. 2, pp. 453–459, 2007. View at Publisher · View at Google Scholar · View at PubMed
  31. A. G. Logan, R. Tkacova, S. M. Perlikowski, R. S. Leung, A. Tisler, J. S. Floras, and T. D. Bradley, “Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex,” European Respiratory Journal, vol. 21, no. 2, pp. 241–247, 2003. View at Publisher · View at Google Scholar
  32. M. A. Martínez-García, R. Gómez-Aldaraví, J. J. Soler-Cataluña, T. G. Martínez, B. Bernácer-Alpera, and P. Román-Sánchez, “Positive effect of CPAP treatment on the control of difficult-to-treat hypertension,” European Respiratory Journal, vol. 29, no. 5, pp. 951–957, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. L. Lozano, J. L. Tovar, and J. L. Tovar, “Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial,” Journal of Hypertension, vol. 28, pp. 2161–2168, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. T. A. Dernaika, G. T. Kinasewitz, and M. M. Tawk, “Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea,” Journal of Clinical Sleep Medicine, vol. 5, no. 2, pp. 103–107, 2009. View at Google Scholar
  35. F. Campos-Rodriguez, A. Grilo-Reina, J. Perez-Ronchel, M. Merino-Sanchez, M. A. Gonzalez-Benitez, M. Beltran-Robles, and C. Almeida-Gonzalez, “Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial,” Chest, vol. 129, no. 6, pp. 1459–1467, 2006. View at Publisher · View at Google Scholar · View at PubMed
  36. F. Campos-Rodriguez, J. Perez-Ronchel, A. Grilo-Reina, J. Lima-Alvarez, M. A. Benitez, and C. Almeida-Gonzalez, “Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea,” Chest, vol. 132, no. 6, pp. 1847–1852, 2007. View at Publisher · View at Google Scholar · View at PubMed
  37. K. Gaddam, E. Pimenta, S. J. Thomas, S. S. Cofield, S. Oparil, S. M. Harding, and D. A. Calhoun, “Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report,” Journal of Human Hypertension, vol. 24, pp. 532–537, 2009. View at Publisher · View at Google Scholar · View at PubMed